Neogen Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Mikhael Nassif
- Full Time Employees
- 2,917
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 620 Lesher Place Lansing MI United States of America 48912
- IPO Date
- Aug 23, 1989
- CIK
- 0000711377
- Website
- neogen.com
- Similar Companies
- Business
- Neogen Corporation (Nasdaq: NEOG), founded in 1982 and headquartered in Lansing, Michigan, develops, manufactures and markets comprehensive solutions for food and animal safety worldwide. The company operates through two primary segments: Food Safety, which offers diagnostic test kits including Reveal for Salmonella Enteritidis, Agri-Screen and Veratox for mycotoxins, NEO-GRID disposable filters, Molecular Detection Assay - Listeria Right Now for rapid Listeria species detection in environmental samples, and products to detect pathogens, toxins, allergens and contaminants in human and animal food; and Animal Safety, which provides veterinary pharmaceuticals, instruments, vaccines, topicals, rodenticides, cleaners, disinfectants, insecticides, genomics testing services for gene isolation, heredity mapping and breeding programs, and over 100 drug detection test kits for approximately 300 abused and therapeutic drugs in farm and racing animals. Neogen serves food manufacturers, processors, regulatory agencies, livestock producers, veterinarians, animal health companies, breeders, agricultural researchers and industries including agriculture and food production across more than 140 countries, with key operations in the United States, Canada, United Kingdom, Europe, Mexico, Brazil, India, China, Australia, Scotland and additional facilities in Kentucky, Wisconsin and Nebraska. In recent developments, Neogen completed the divestiture of its global cleaners and disinfectants business to Kersia Group in July 2025 for $130 million in cash plus contingent consideration, using net proceeds including $100 million to reduce debt and enhance focus on core diagnostics; appointed Mike Nassif as president and chief executive officer effective August 11, 2025, succeeding John Adent, alongside Bryan Riggsbee as chief financial officer in November 2025 and Avi Pelossof to the board in October 2025; formed a strategic partnership with Biomatter to develop AI-enabled enzyme-based products for food safety testing; renewed sponsorship with the United States Equestrian Federation in 2025 to advance equine botulism prevention education tied to its BotVax B vaccine; launched the Listeria Right Now molecular assay in 2025; and reaffirmed fiscal 2026 guidance of $820 million to $840 million in revenue and $165 million to $175 million in adjusted EBITDA following first-quarter results and restructuring with headcount reductions. The company resulted from the 2022 merger with 3M's food safety business, expanding its diagnostics portfolio and global presence.
Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
NEOG Q3 Earnings & Revenues Top, Gross Margin Down, Stock Crashes
Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results
Neogen Corporation (NEOG) Q3 2026 Earnings Call Transcript
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Neogen (NEOG) Beats Q3 Earnings and Revenue Estimates
Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren't Helping.
Neogen Reports Third Quarter Fiscal Year 2026 Financial Results
Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Countdown to Neogen (NEOG) Q3 Earnings: Wall Street Forecasts for Key Metrics
Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline
Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026
SG Americas Securities LLC Purchases 1,460,488 Shares of Neogen Corporation $NEOG
Contrasting Sunny Optical Technology (Group) (OTCMKTS:SNPTF) and Neogen (NASDAQ:NEOG)
CIBC Bancorp USA Inc. Makes New $28.97 Million Investment in Neogen Corporation $NEOG
Clarkston Capital Partners LLC Has $66.77 Million Position in Neogen Corporation $NEOG
Neogen Announces Sale of Genomics Business to Zoetis
Neogen Corporation (NASDAQ:NEOG) Receives Average Recommendation of “Hold” from Brokerages